Picture of 23andMe Holding Co logo

MEHCQ 23andMe Holding Co Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Annual income statement for 23andMe Holding Co, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2021
March 31st
2022
March 31st
R2023
March 31st
R2024
March 31st
2025
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUS10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue244272299220190
Cost of Revenue
Gross Profit11713313297.9100
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses429526523801433
Operating Profit-185-254-223-582-243
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-184-221-213-567-235
Provision for Income Taxes
Net Income After Taxes-184-217-211-567-235
Net Income Before Extraordinary Items
Extraordinary Items
Net Income-184-217-312-667-281
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-184-217-312-667-281
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-84.3-12-9.0534.2-6.98